Inactive Instrument

Plandaí Biotechnology, Inc. Stock Other OTC

Equities

PLPL

US72703D1000

Investment Holding Companies

Sales 2015 0.09 Sales 2016 0.3 Capitalization 5.94M
Net income 2015 -9M Net income 2016 -4M EV / Sales 2015 561,083,715 x
Net Debt 2015 16.01M Net Debt 2016 15.8M EV / Sales 2016 72,815,310 x
P/E ratio 2015
-3.47 x
P/E ratio 2016
-1.32 x
Employees -
Yield 2015 *
-
Yield 2016
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC. CI
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc CI
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC. CI
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction. CI
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction. CI
Plandaí Biotechnology, Inc. Addresses Bioavailability and the Science of Phytofare from Previous Human Clinical Trial Results CI
Plandai Biotechnology Announces Phytofare to Be Focus of Human Clinical Trial for Type II Diabetes in Mauritius CI
Plandai Biotechnology Executes Exclusive Distribution Agreement with Cambridge Commodoties for UK and All of Europe CI
Plandaí Biotechnology, Inc. Receives 1.2 Million Origine 8 Capsule Order from Coyne Healthcare CI
Plandai Biotechnology, Inc Appoints Ezra Jones as Vice President of Sales and Marketing CI
NutriBullets SuperFood Boost Featuring Plandai Biotechnology's Phytofare Expected to Hit Retailers in May 2017 CI
Plandaí Biotechnology, Inc. Names Callum Cottrell-Duffield as President and Chief Operating Officer CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million. CI
Plandai Biotechnology Enters Pact in Principal with North West University for New Clinical Trials to Evaluate Effectiveness of Phytofare in Treating Type II Diabetes CI
Plandaí Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt CI
More news
Managers TitleAgeSince
Chief Executive Officer 68 -
Members of the board TitleAgeSince
Chief Executive Officer 68 -
More insiders
Plandai Biotechnology, Inc. is a biotech company, which is focused on the production of botanical extracts for the nutraceutical and pharmaceutical industries. The Company grows the green tea used in its products on a 3,000-hectare estate in the Mpumalanga region of South Africa. Its marketed product, Phytofare Catechin Complex, is a green-tea-derived extract that has multiple potential wellness applications. It caters to airline flights and operated coffee shops, lounges and gift shops at airports, and other facilities located in Florida, Alabama, and Georgia. Its airline catering services include the preparation of meals in kitchens located at, or adjacent to, airports and the distribution of meals and beverages for service on commercial airline flights. The Company also provides certain ancillary services, including the preparation of beverage service carts, the unloading and cleaning of plates, utensils and other accessories arriving on incoming aircraft, and other.
More about the company